HSR20-095: Progression-Free Survival, Overall Survival, and Tumor Response for Patients Diagnosed With Small Cell Lung Cancer Who Received First-Line Systemic Therapy

Authors:
Junji Lin Concerto HealthAI, Boston, MA

Search for other papers by Junji Lin in
Current site
Google Scholar
PubMed Close
 PhD
,
Santosh Gautam Concerto HealthAI, Boston, MA

Search for other papers by Santosh Gautam in
Current site
Google Scholar
PubMed Close
 PhD
,
Nan Hu Concerto HealthAI, Boston, MA

Search for other papers by Nan Hu in
Current site
Google Scholar
PubMed Close
 MS
,
Debra Wertz Concerto HealthAI, Boston, MA

Search for other papers by Debra Wertz in
Current site
Google Scholar
PubMed Close
 PharmD
,
Gboyega Adeboyeje Merck & Co., Inc., North Wales, PA

Search for other papers by Gboyega Adeboyeje in
Current site
Google Scholar
PubMed Close
 MD, MS, MBA
, and
Sumesh Kachroo Merck & Co., Inc., North Wales, PA

Search for other papers by Sumesh Kachroo in
Current site
Google Scholar
PubMed Close
 PhD
Volume/Issue:
Volume 18: Issue 3.5
Online Publication Date:
20 Mar 2020
DOI:
https://doi.org/10.6004/jnccn.2019.7428
Restricted access

Corresponding Author: Junji Lin, PhD
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2020 by the National Comprehensive Cancer Network 2020
Article Category:
Abstract
Print Publication Date:
20 Mar 2020
Online Publication Date:
20 Mar 2020

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 745 278 168
PDF Downloads 281 0 0
EPUB Downloads 0 0 0